AMSTERDAM, January 8, 2015 /PRNewswire/ --
High-tech publishing platform to be developed in cooperation with researchers, offering a new publishing option tailored to their needs
Elsevier, a world-leading provider of scientific, technical and medical information products and services, has announced it is developing a new open access journal covering all disciplines. The journal will be developed in close cooperation with researchers, enabling continuous improvement in line with their needs and feedback. The official launch is planned in 2015.
The new journal will be as much technology-driven as it will be community-driven. Authors are to enjoy a step-by-step, quick and intuitive submission and publishing experience. Data from and technology behind Scopus will enable efficient matching of papers to relevant editors and reviewers, shortening peer review times. Also, integrated smart technologies, developed at Elsevier and Mendeley, will make papers easily discoverable and will connect them to the relevant research communities and readers.
Philippe Terheggen, Managing Director of Elsevier Journals, said, "We're in the business of supporting researchers to advance science. The new journal embodies that mission. It leverages Elsevier's full potential for the benefit of researchers, by combining quality content with our technological innovations that enable broad content visibility and access, and by facilitating sharing and collaboration. Moreover, we will use the journal as a platform for experimentation and innovation and we'll take the learnings from this journal to enhance our full portfolio of journals."
Claudia Lupp, Editor-in-Chief of the journal, said, "We invite the research community to be our collaborators in innovative publishing. Researchers know best what they need in terms of publishing options and requirements, and we have the technology that allows us to implement new features and services based on their feedback."
The journal will open for submissions in the course of 2015. Members of the international researcher community who have constructive ideas that help to further develop this journal are welcome to submit their feedback. More information is available on Elsevier Connect.
Elsevier is the world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes nearly 2,500 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Mary Beth O'Leary
Marketing & Publicity Manager